TEL AVIV, ISRAEL--(Marketwire - May 23, 2011) -
BioTech Medics, Inc., (PINKSHEETS: BMCS
) announced today that it is being represented at the 10th anniversary of ILSI-BioMed Israel Week by MicroCap Review Magazine. ISLI-BioMed is the largest life science convention outside the USA. More than 1,000 are registered to attend.
"This is a part of a major SHBAN Alcohol Free Hand Sanitizer awareness and branding campaign for 2011," said Tom Wood, V.P. of Sales. "Additionally we have redesigned and expanded our www.shban.com web site to include a secure online shopping cart. BioTech announced in January it was making a major marketing emphasis and we are keeping our promise to our investors."
"BioTech has commenced a series of 60 second SHBAN TV commercial ads on Family Net HD TV Cable to 25 million cable households. Additionally BioTech has contracted with an Irving, Texas fulfillment center that can handle the SHBAN marketing orders," added Mr. Wood.
SHBAN's new marketing slogan for 2011 will be "You wouldn't think of wearing a deodorant for one minute; so why are you using an alcohol hand sanitizer that only lasts a minute!"
SHBAN is superior to alcohol hand sanitizers because it is long lasting and non-flammable. Alcohol hand sanitizers are a Class I fire hazard. The alcohol gel containers are like having a jar of napalm on your desk or in your pocket or purse. Additionally, the Poison Control centers have reported over 22,000 children and adults with alcohol poisoning from ingesting alcohol gels. SHBAN is a green product made with derivatives of sea weed and sea kelp. SHBAN's active ingredient is FDA approved as an antiseptic as well as an antimicrobial solution. SHBAN is colorless and will not stain most materials and jewelry. SHBAN is gentle on hands.
Safe Harbor: Forward-Looking Statements
This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed. The FDA has not evaluated the SHBAN statements above. SHBAN is not intended to diagnose, treat or cure any disease.